Pages that link to "Q45269766"
Jump to navigation
Jump to search
The following pages link to Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome (Q45269766):
Displaying 26 items.
- Dopamine agonists for the treatment of restless legs syndrome (Q24235988) (← links)
- Strategies for the treatment of restless legs syndrome (Q26829911) (← links)
- (Q27024854) (← links)
- Ropinirole in restless legs syndrome and periodic limb movement disorder (Q33802191) (← links)
- The use of gabapentin enacarbil in the treatment of restless legs syndrome (Q34409544) (← links)
- Medication tolerance and augmentation in restless legs syndrome: the need for drug class rotation (Q35901664) (← links)
- Emerging drugs for restless legs syndrome (Q36219646) (← links)
- Dopamine agonists for the treatment of restless legs syndrome. (Q36326234) (← links)
- Ropinirole, a non-ergoline dopamine agonist. (Q36358853) (← links)
- Management of restless legs syndrome in patients on dialysis. (Q36451420) (← links)
- Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. (Q36659132) (← links)
- A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome (Q37083130) (← links)
- Restless legs syndrome: pathophysiology, diagnosis and treatment (Q37165507) (← links)
- Ropinirole for the treatment of restless legs syndrome (Q37166108) (← links)
- Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke (Q37176052) (← links)
- A double-blind, randomized, controlled trial to compare the efficacy and tolerability of fixed doses of ropinirole, bupropion, and iron in treatment of restless legs syndrome (Willis-Ekbom disease). (Q37484385) (← links)
- Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose? (Q37577779) (← links)
- Emerging therapies for fibromyalgia: an update (Q37756999) (← links)
- Restless legs syndrome: pathophysiology, clinical presentation and management (Q37763512) (← links)
- Long‐term management issues in restless legs syndrome (Q37871513) (← links)
- Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome (Q43202454) (← links)
- Recent advances in the diagnosis, genetics and treatment of restless legs syndrome. (Q46010981) (← links)
- Absence of cardiovascular disease risk factors in restless legs syndrome. (Q48295342) (← links)
- The efficacy and tolerability of rotigotine on patients with periodic limb movement in sleep: A systematic review and meta-analysis. (Q55302709) (← links)
- Le syndrome des jambes sans repos (Q60490509) (← links)
- Restless legs syndrome (Q80129194) (← links)